A globally accomplished strategist, analyst and communicator, Iain has more than 20 years’ experience in the life sciences and health sectors in Australia and globally.
Iain was the co-founder and editor of Australian Biotechnology News, Australia’s first biotechnology business daily news service, which he managed for five years before moving to the UK. In London, he worked for Mergermarket, where he provided highly specialised analysis of pharmaceuticals for the investment sector, before moving to the role of Managing Editor at the Economist Intelligence Unit.
More recently, he was EY’s European life sciences analyst, based in Zürich, where he worked closely with the firm’s leadership and pharmaceutical and medtech clients.
“We’re delighted to welcome someone of Iain’s deep expertise across the global healthcare sector to the ANDHealth team,” said ANDHealth Founder & CEO Bronwyn Le Grice. “Iain brings a wealth of experience and capability to our operations and significantly increases our ability to leverage our deep intelligence on Australia’s growing digital health sector into increased awareness and engagement across Australia and overseas.”
Iain will be focusing on utilising ANDHealth’s deep industry data and global networks to support ANDHealth’s programs and broader activities including liaising with members and key stakeholders and the development and publication of outcomes of industry research and global trends data.
In his new role, Iain is committed to raising the profile and understanding of Australia’s rapidly emerging digital health sector. “There is so much energy and passion in the Australian digital health community, and so many technologies addressing real, unmet clinical and health economics needs,” he says. “ANDHealth’s contribution to that drive is enormous, and it is a real privilege to join them and play a part in the development of this dynamic ecosystem.”